News

Clinical trials have been completed evaluating the efficacy and safety of Humira in a range of moderate-to-severe Crohn's disease patients. In these trials, Humira demonstrated statistical significance in

Crestor has already been shown to be the most effective of the statins (cholesterol lowering medicines) at reducing “bad” cholesterol or LDL-C, enabling most patients with high cholesterol

The complaint filed in US District Court in the Eastern District of Texas, Marshall Division, says the package insert that came with Ortho Evra was misleading and in

The trial tested those who underwent hernia repair surgery. The trial results indicate that LidoPAIN did not achieve a statistically significant effect relative to placebo with respect to

In the study of a large animal model, stoppage of the heart was induced in two groups for about 18 minutes while either a modified AT-101 motion platform

Acute porphyria is designated as an orphan disease by the FDA. Panhematin is the only FDA-approved therapy for acute porphyria, which makes the therapy vital for the treatment

The data demonstrated greater potency and specific activation of the immune response when HspE7 was combined with either of the two adjuvants studied. “These data suggest that combining

The plan consists of three phase III efficacy trials, the first of which is currently ongoing in knee osteoarthritis in the US, with an additional, similarly designed knee

Heart disease patients who were at a very high risk for having a second heart attack and took Lipitor had a 46% reduction in the risk of a